| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Enveric Biosciences, Inc. (ENVB) has 7 insiders with recent SEC Form 4 filings, including 3 buys and 0 sells. ENVB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 70.4K | $200.5K | - | |
| CFO | 47.4K | $135.1K | - | |
| Dir | 7.9K | $22.5K | - | |
| Dir | 7.9K | $22.5K | - | |
| Dir | 7.9K | $22.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 2, 2015 | Eberwein Jeffrey E.66 | Director, 10% Owner | Buy | 12 | $2.00 | $24.00 | +0.2% | |
| Jun 18, 2015 | Eberwein Jeffrey E.66 | Director, 10% Owner | Buy | 1 | $2.51 | $2.51 | - | |
| Jun 15, 2015 | Eberwein Jeffrey E.66 | Director, 10% Owner | Buy | 5,000 | $2.43 | $12,144.00 | New |